NewAmsterdam Pharma Company N.V. - NAMS

About Gravity Analytica
Recent News
- 04.17.2025 - NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors
- 04.17.2025 - NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors
- 04.07.2025 - 24th Needham Virtual Healthcare Conference
- 04.07.2025 - 24th Needham Virtual Healthcare Conference
- 04.04.2025 - NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- 04.04.2025 - NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- 03.31.2025 - NewAmsterdam Pharma to Present at the 24th Annual Needham Virtual Healthcare Conference
- 03.31.2025 - NewAmsterdam Pharma to Present at the 24th Annual Needham Virtual Healthcare Conference
Recent Filings
- 04.17.2025 - 8-K Current report
- 04.17.2025 - EX-99.1 EX-99.1
- 04.17.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.17.2025 - 3 Initial statement of beneficial ownership of securities
- 04.17.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.11.2025 - 144 Report of proposed sale of securities
- 03.28.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.28.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.28.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.28.2025 - 4 Statement of changes in beneficial ownership of securities